Live Vaccine PULVAC E. COLI

Colibacillosis is one of the most common bacterial infections in poultry farming, causing damage to internal organs, reduced growth rates, and significant mortality in flocks. To effectively control this disease, Zoetis has developed the live non-reactogenic vaccine PULVAC E. COLI. The product is based on an avirulent culture of Escherichia coli (strain EC34195), ensuring a strong immune response without complications for bird health.

The main advantage of PULVAC E. COLI for industrial poultry production is its versatility and proven ability to provide broad cross-protection against different serotypes of E. coli. The vaccine can be administered to chicks and turkey poults from one day of age. Thanks to the possibility of application by coarse spray (spray method) or via drinking water, vaccination of large flocks becomes fast and convenient for farm personnel. Immunity develops within 10–14 days and remains at a high level up to 45 weeks of age with timely revaccination.

Introducing PULVAC E. COLI into the veterinary program of your poultry farm is a strategic step toward reducing dependence on antibiotics and improving production biosecurity. A protected flock demonstrates higher survival rates, better uniformity, and optimal feed conversion. It is a reliable investment in poultry health that protects production performance and ensures stable profitability in agribusiness.